Veterinary Medicines

Endogard Plus XL Tablets for dogs

Authorised
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Endogard Plus XL Tablets for dogs
Endogard plus XL tabletten voor honden
Active substance:
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    525.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    175.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    504.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC55
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Print and perforated Alu-Alu blister: 2 tablets (1 blister with 2 tablets), in a box.
  • Print and perforated Alu-Alu blister: 4 tablets (2 blisters with 2 tablets), in a box.
  • Print and perforated Alu-Alu blister: 10 tablets (1 blister with 10 tablets), in a box.
  • Print and perforated Alu-Alu blister: 12 tablets (2 blisters with 6 tablets), in a box.
  • Print and perforated Alu-Alu blister: 24 tablets (4 blisters with 6 tablets), in a box.
  • Print and perforated Alu-Alu blister: 30 tablets (3 blisters with 10 tablets), in a box.
  • Print and perforated Alu-Alu blister: 30 tablets (5 blisters with 6 tablets), in a box.
  • Print and perforated Alu-Alu blister: 50 tablets (5 blisters with 10 tablets), in a box
  • Print and perforated Alu-Alu blister: 60 tablets (10 blisters with 6 tablets), in a box.
  • Print and perforated Alu-Alu blister: 60 tablets (6 blisters with 10 tablets), in a box.
  • Print and perforated Alu-Alu blister: 100 tablets (10 blisters with 10 tablets), in a box.
  • Print and perforated Alu-Alu blister: 102 tablets (17 blisters with 6 tablets), in a box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka-Farma d.o.o.
  • Virbac
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 104802
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0539/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 2/09/2025
Download

Summary of Product Characteristics

English (PDF)
Published on: 13/10/2024
Download